Topic: Drug reform

Conference coverage: 2019 Face to Face Drug Plan Management Forum

Benefits Canada | January 17, 2020 / News

Is innovation causing accessibility, timing issues for private drug plans?

Cassandra Williamson-Hopp | January 17, 2020 / Health/wellness

Collaboration fundamental when managing, altering private drug plans

Cassandra Williamson-Hopp | January 17, 2020 / Health benefits

Draft PMPRB guidelines include changes to reference countries, drug price factors

Staff | November 25, 2019 / News

Proposed changes to Ontario drug rules target generics pricing, biosimilar listing process

Staff | November 14, 2019 / News

Alberta budget includes changes to public pensions, expanded biosimilars initiative

Kelsey Rolfe | October 28, 2019 / News

Editorial: Federal election promises must focus on Canada’s evolving workforce

Jennifer Paterson | October 18, 2019 / News

Liberals pledging to boost investments in mental health, pharmacare

Staff | September 24, 2019 / News

Institutional investors urging Congress to vote down CUSMA, citing effect on drug prices

Kelsey Rolfe | September 23, 2019 / News

Federal election platforms include health-care, pension policy proposals

Staff | September 17, 2019 / News